Neurophth Therapeutics
Website:
Neurophth Therapeutics
Business Area(s)
Description
Neurophth Therapeutics develops gene therapies using adeno-associated viral (AAV) vectors to treate inherited blindness. The company's lead project, NR082( NFS-01,rAAV2-ND4), is designed to treat Leber's hereditary optic neuropathy (LHON), a maternally inherited degenerative disease leads to serious visual loss which there is currently no effective treatment.
Career Page(s)
Company Location(s)
C270-C271, 3rd Floor, Building B1, Optics Valley Biological City, No.666 Gaoxin Avenue
Wuhan City
Hubei
China
No.218 Xinghu Street, Suzhou Industrial Park,
Jiangsu
China
No. 1799, Wuzhong Road
Shanghai
China
200 Continental Drive, Suite 401, Rm 411
Newark, DE 19713
United States